The Procter & Gamble Company's Stock Analysis

Procter & Gamble Closes $258.9 Million Note Offering

The Procter & Gamble Company has successfully completed an underwritten public offering of Floating Rate Notes, totaling $258,889,000. These notes are due on November 4, 2075 and were issued under the company's existing Registration Statement on Form S-3.

Legal opinions related to the notes have been included as part of the filing. This offering may affect the company's financial position and liquidity, which are key considerations for investors.

Nov 04, 2025 16:16:00

Procter & Gamble Closes €1 Billion and $1.25 Billion Offerings

On November 3, 2025, The Procter & Gamble Company completed an underwritten public offering totaling €500 million in 2.900% Notes due in 2033 and €500 million in 3.650% Notes due in 2045. This issuance was conducted under the company's Registration Statement on Form S-3.

Additionally, the company closed another public offering of $750 million in 4.100% Notes due in 2032 and $500 million in 4.350% Notes due in 2035, also under the same Registration Statement. Legal opinions related to these offerings have been attached as exhibits to the report.

Nov 03, 2025 16:23:10

Procter & Gamble Reports Q1 FY 2026 Financial Results

On October 24, 2025, Procter & Gamble announced its first quarter results for FY 2026, reporting a 2% growth in organic sales driven by pricing and mix, despite a challenging market environment. Core earnings per share (EPS) increased by 3% year-over-year, reaching $1.99, while organic volume growth remained flat. The company noted that 8 out of 10 product categories either grew or maintained their organic sales during this quarter, although the global aggregate value share declined by 30 basis points.

For the fiscal year 2026, Procter & Gamble provided guidance indicating expected organic sales growth of 0% to 4% and net sales growth of 1% to 5%. Core EPS is projected to grow between 0% to 4%, with all-in EPS growth anticipated to be between 3% to 9%. The company also highlighted various potential headwinds that could impact these projections, including commodity cost increases and geopolitical disruptions. Investors may want to consider these factors when assessing the company's outlook.

Oct 24, 2025 10:10:46

Procter & Gamble Reports Q1 Fiscal 2026 Financial Results

The Procter & Gamble Company reported first quarter fiscal year 2026 net sales of $22.4 billion, marking a three percent increase compared to the previous year. Organic sales, which exclude foreign exchange and acquisitions, rose two percent, driven by a one percent increase from higher pricing and a one percent increase from a favorable sales mix. Diluted net earnings per share reached $1.95, up 21% year-over-year, while core earnings per share increased three percent to $1.99. The company's operating cash flow was $5.4 billion, with net earnings totaling $4.8 billion for the quarter. P&G returned $3.8 billion to shareholders through dividend payments and share repurchases during this period.

For fiscal year 2026, Procter & Gamble maintained its guidance for all-in sales growth between one to five percent and organic sales growth in line with or up to four percent. The company anticipates diluted net earnings per share growth between three to nine percent. P&G expects commodity cost headwinds of approximately $100 million and higher tariff costs of about $400 million. Despite these challenges, the company projects a favorable foreign exchange tailwind of around $300 million after tax and plans to allocate about $10 billion for dividends and $5 billion for share repurchases in fiscal 2026.

Oct 24, 2025 07:04:27

Procter & Gamble Approves 2025 Stock Incentive Compensation Plan

At the Annual Meeting of Shareholders on October 14, 2025, Procter & Gamble shareholders approved the 2025 Stock and Incentive Compensation Plan, which allows for the award of up to 175 million shares of common stock. The plan includes various types of awards such as stock options and restricted stock units, and it also incorporates shares remaining from the 2019 Stock Plan. The Board of Directors had previously approved this plan for submission to shareholders on August 12, 2025.

During the same meeting, shareholders elected directors for a one-year term, ratified the appointment of the independent registered public accounting firm, and approved an advisory vote on executive compensation. Additionally, the 2025 Stock Plan received approval, while a shareholder proposal requesting more reporting on plastic packaging was not approved. The outcomes of these votes may have implications for the company's governance and compensation strategies.

Oct 16, 2025 16:25:14

Procter & Gamble Declares Quarterly Dividend and Board Elections

The Procter & Gamble Company announced a quarterly dividend of $1.0568 per share on both its Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock. This dividend will be payable on or after November 17, 2025, to shareholders of record as of October 24, 2025. The company has a long history of dividend payments, having paid dividends for 135 consecutive years and increased them for 69 consecutive years, highlighting its commitment to returning cash to shareholders.

During the Annual Meeting of Shareholders, all fourteen Director nominees were elected to the Board, receiving strong preliminary support. Shareholders also approved several Board proposals, including the ratification of the independent registered public accounting firm and an advisory vote on executive compensation. Additionally, a proposal for more reporting on flexible plastic packaging was voted down. Final voting results will be certified and announced in a subsequent filing.

Oct 14, 2025 10:55:51

CEO of Procter & Gamble Beauty to Retire in 2026

Alexandra Keith, the Chief Executive Officer of Beauty at Procter & Gamble, announced her retirement effective February 20, 2026, after over 36 years with the company. Upon her retirement, she will enter into a standard Written Separation Agreement, which does not include a cash severance payment but allows her to keep a special equity award set to vest in August 2026.

Additionally, all other equity awards held by Ms. Keith will either be retained or pro-rated according to the terms outlined in the applicable Award Agreement. This leadership change may be relevant for investors monitoring the company's management structure and future strategic direction.

Aug 14, 2025 10:00:31

Procter & Gamble Reports Fiscal Year 2025 Financial Results

On July 29, 2025, Procter & Gamble announced its financial results for the fourth quarter and fiscal year 2025. The company achieved a 2% growth in organic sales, driven by both volume and pricing, with core earnings per share increasing by 4% to $6.83. Despite challenges in the macroeconomic environment, nine out of ten product categories saw organic sales growth. The company returned $6.5 billion to shareholders through dividends and share repurchases, maintaining an adjusted free cash flow productivity of 87% for the year.

For fiscal year 2026, Procter & Gamble provided guidance indicating expected organic sales growth between 0% to 4% and core EPS growth of 0% to 4%. The company anticipates various headwinds including commodity cost increases and geopolitical disruptions, which may impact earnings. The planned capital spending is projected to be 4% to 5% of sales, with around $10 billion allocated for dividends and $5 billion for direct share repurchases.

Jul 29, 2025 10:51:39

Procter & Gamble Reports Fiscal Year 2025 Financial Results

The Procter & Gamble Company reported net sales of $84.3 billion for fiscal year 2025, remaining unchanged from the previous year. Organic sales increased by two percent, attributed to higher pricing and stable volume. The diluted net earnings per share rose to $6.51, an eight percent increase year-over-year. The company returned over $16 billion to shareholders through dividends and share repurchases, marking the 69th consecutive year of dividend increases. The fourth quarter saw net sales of $20.9 billion, a two percent increase, with diluted net earnings per share at $1.48, a 17 percent rise compared to the prior year.

Looking ahead, Procter & Gamble expects fiscal year 2026 sales growth between one to five percent, with organic sales growth projected to be flat to up four percent. The company anticipates diluted net earnings per share growth of three to nine percent from the previous year. It has initiated a restructuring plan, expecting to incur non-core restructuring costs of approximately $1 to $1.6 billion over two years. Additionally, the company plans to maintain a capital spending estimate of four to five percent of net sales and aims for adjusted free cash flow productivity of 85% to 90%.

Jul 29, 2025 07:03:15

Procter & Gamble Announces CEO Transition and Executive Changes

On July 28, 2025, Procter & Gamble announced that Jon Moeller will transition from his role as President and Chief Executive Officer to become Executive Chairman of the Board, effective January 1, 2026. Shailesh Jejurikar, currently the Chief Operating Officer, has been elected to succeed Moeller as President and CEO, also effective January 1, 2026. Jejurikar has been with the company since 1989 and has held various leadership roles, including Chief Executive Officer of Global Fabric and Home Care. He has been nominated to stand for election to the Board at the annual shareholder meeting in October 2025.

As part of the transition, Jejurikar will receive an annual base salary of $1.6 million and will participate in the company's annual incentive program. He has also been granted a long-term incentive award valued at $14 million. Moeller will have an annual base salary of $1.2 million in his new role as Executive Chairman and will also receive a long-term incentive award of $15 million. Both executives will continue to participate in the company's executive compensation and benefit programs, which are detailed in the definitive proxy statement dated August 23, 2024.

Jul 28, 2025 17:03:12